Clinical trial readout dates for Incyte Corporation, compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced. The next expected readout is December 2026.
The registry reports these trials have finished collecting primary data. Results often follow within months, and the company may already have reported.
| Phase 2 Axatilimab Chronic Graft-versus-host-disease · NCT06388564 | October 2026 Primary data collected |
| Phase 3 Ruxolitinib Cream Hidradenitis Suppurativa · NCT06958211 | October 2026 Primary data collected |
| Phase 3 Ruxolitinib Atopic Dermatitis · NCT06832618 | August 2026 Primary data collected |
| Phase 2 retifanlimab Endometrial Cancer · NCT04463771 | May 2026 Primary data collected |
| Phase 3 Povorcitinib Hidradenitis Suppurativa (HS) · NCT06212999 | December 2026 Ongoing |
| Phase 1/2 INCA034176 Chronic Graft-versus-host-disease · NCT06843408 | January 2027 Ongoing |
| Phase 2 INCB123667 Ovarian Cancer · NCT07023627 | April 2027 Recruiting |
| Phase 3 Ruxolitinib Cream NonSegmental Vitiligo · NCT06804811 | April 2027 Recruiting |
| Phase 2 INCB000928 Fibrodysplasia Ossificans Progressiva (FOP) · NCT05090891 | July 2027 Recruiting |
| Phase 2 Tafasitamab Hematologic Malignancies · NCT06465433 | August 2027 Recruiting |
These dates have elapsed; the company may have reported, or guidance may have shifted.
| Phase 2 Parsaclisib B-Cell Malignancies · NCT04509700 | November 2026 Ongoing |
| Phase 2 povorcitinib Moderate to Severe Asthma · NCT05851443 | November 2026 Ongoing |
Incyte Corporation reported $3.28B in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-10-29). Its net loss for that quarter was $785M; at that rate the cash would last about 4 quarters. This is a rough guide: net loss includes non-cash items such as stock compensation, and does not count money the company may raise, so its own runway guidance can differ.
| 8-K Other Events — often topline trial data | 2026-11-13 |
| 8-K Results of Operations — earnings, may carry pipeline updates | 2026-10-29 |